Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma

BACKGROUND: Bleomycin hydrolase (BLMH), an enzyme that inactivates bleomycin, may be a potential candidate that could influence pulmonary function in ABVD (doxorubicin, bleomycin, vinblastin, dacarbasine)–treated Hodgkin lymphoma (HL) patients. PATIENTS AND METHODS: We hypothesized that the BLMH gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Jóna, Ádám, Miltényi, Zsófia, Póliska, Szilárd, Bálint, Bálint László, Illés, Árpád
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915614/
https://www.ncbi.nlm.nih.gov/pubmed/27327270
http://dx.doi.org/10.1371/journal.pone.0157651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915614/
https://www.ncbi.nlm.nih.gov/pubmed/27327270
http://dx.doi.org/10.1371/journal.pone.0157651

Ejemplares similares